Usted buscó: adverse experience (Inglés - Lituano)

adverse experience rate
Šalutinio poveikio

in terms of overall adverse experience, and
kaip jie apskritai pasireiškė ir

potential adverse experiences
· galimi nepageidaujami pojciai

the adverse experience profile for paediatric patients appears to be similar to that seen in adult patients.
pediatrijos pacientams pasireiškiantys nepageidaujami reiškiniai panašūs į suaugusių pacientų.

few individuals (0.1%) discontinued due to adverse experiences.
keli tiriamieji (0,1 %) dėl nepageidaujamų reakcijų dalyvavimą nutraukė.

these occurrences did not result in clinically important adverse experiences.
tai nesukl kliniskai reiksming nepageidaujam reakcij.

most adverse experiences reported in these clinical studies were described as mild to moderate in intensity.
dauguma si klinikini tyrim metu pasireiskusi nepageidaujam reiskini buvo nestiprs arba vidutinio stiprumo.

psychiatric symptoms: psychiatric adverse experiences have been reported in patients treated with efavirenz.
psichikos sutrikimai.efavirenzu gydytiems pacientams pasitaik nepageidaujam poveiki psichikai.

106 psychiatric symptoms: serious psychiatric adverse experiences have been reported in patients treated with efavirenz.
psichikos sutrikimai.efavirenzu gydytiems pacientams pasitaik sunki psichikos sutrikim.

patients with a prior history of psychiatric disorders appear to be at greater risk of these serious psychiatric adverse experiences.
pacientams, kuriems anksciau buvo psichikos sutrikim, yra didesn sunki nepageidaujam poveiki psichikai rizika.

there have been reports of acute overdosage with etoricoxib, although adverse experiences were not reported in the majority of cases.
gauta pranešimų apie etorikoksibo ūmaus perdozavimo atvejus, nors daugumoje jų nepageidaujamų pojūčių nepastebėta.

when taken with certain other medications, lyrica may potentiate the adverse experiences seen with these drugs, including respiratory failure and coma.
kartu su kai kuriais kitais vaistais vartojamas lyrica gali sustiprinti si vaist salutin poveik, skaitant kvpavimo nepakankamum ir kom.

there were no vaccine-related serious adverse experiences reported in infants who were breast-feeding during the vaccination period.
skiepijimo laikotarpiu žindytiems naujagimiams su vakcina susijusių sunkių nepageidaujamų reiškinių nebuvo.

the most frequently observed adverse experiences were consistent with the safety profile for etoricoxib (e. g. gastrointestinal events, cardiorenal events).
dažniausiai stebėti nepageidaujami pojūčiai atitiko žinomas etorikoksibo saugumo savybes (pvz., nepageidaujami virškinimo trakto, širdies ar inkstų reiškiniai).

1) discontinuation for upper gi symptoms; 2) discontinuation for any gi adverse experiences; 3) new use of gastroprotective medications; and 4) new use of any gi medications.
1) nutrauktas gydymas dl virsutins vt dalies pozymi; 2) nutrauktas gydymas dl bet koki vt nepageidaujam reakcij; 3) poreikis pradti vartoti skrand apsaugancius vaistus; 4) poreikis pradti gydytis bet kokiais vt vaistais.